疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

7 R. A( J3 k0 e. `% J& M, B9 |http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

SECTION 1: General aspects of vaccination
. e) c$ h" s* G1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
  w( {. h- l) O# \2 z: g5 Evolution of adjuvants across the centuries 58
( v- h! U) y) a  k& p$ u6 Vaccine additives and manufacturing residuals in the United States:
5 K6 g( l% G" [; C8 t. [9 ~7 ~% Ilicensed vaccines 71
7 Passive immunization 80
; u! H8 h/ }2 ~. C3 a# M  [8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
; n3 @9 m) q1 w6 h10 Anthrax vaccines 127
11 Cholera vaccines 141
) v" O7 ?  Z9 K( J- ?- `12 Diphtheria toxoid 153
& x& ~& j% d' ~8 _! C. w& ~13 Haemophilus influenzae vaccines 167
" @$ X; U8 l, R1 I5 c- ~0 W14 Hepatitis A vaccines 183
$ X4 N' s' [# u  d1 \$ G15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
% z- o5 m! _, \( i: g" M17 Inactivated influenza vaccines 257
4 S; Y, W% w: T+ g18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
' K, ~! N+ @9 a  [! e21 Meningococcal vaccines 388
6 ^$ `5 {5 |2 {) L22 Mumps vaccine 419
+ j4 ~) |* H- @' _' G23 Pertussis vaccines . 447
/ S) d. c- }5 p6 P24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
; T- G  b# }# l, B9 g' z26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
3 u9 m+ p# }9 L% t# `; g28 Poliovirus vaccine-live 598
4 o& D  ~3 u( G/ @8 R% Y29 Rabies vaccines .646
. M# {# c8 j! ]& y( E30 Rotavirus vaccines . 669
31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
2 s! _5 n1 b8 M% s$ e34 Tick-borne encephalitis virus vaccines 773
4 ~. S+ g+ ]; v$ x' ?/ `35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
* A' C! {1 b3 a! Q9 L" I37 Varicella vaccine 837
38 Yellow fever vaccine 870
7 {- @: Q/ Y: w. r$ V7 Z% w39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
2 i$ A8 J. U" |9 s6 t45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
& [0 w; g. ^) q' _7 y3 a9 W49 Hepatitis E vaccines 1085
! B# m% Y2 c2 [4 i50 Herpes simplex virus vaccines 1090
' U( @( [7 G  O4 }& r, j51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
1 K0 q9 W+ O1 @" q# j! r7 j58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
3 a4 _1 t+ Y' [4 A60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
; `$ r! G. r, N1 H  _7 G& ]$ c62 The development of gene-based vectors for immunization 1232
/ o( p9 P3 c7 O, h0 `, |SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
$ [& ]5 H. A4 T) }9 \+ A% \! m9 @& f64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
: o1 J& w+ i0 g8 M5 c1 g66 Vaccines for health care personnel 1290
0 X. F1 P- @  G5 W0 gSECTION 5: Public health and regulatory issues
5 S! S, W6 d  ]* `/ Z% S/ P! e' [3 T67 Immunization in the United States 1310
6 O9 O# r: a' M: V68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
- G, H# g' Y; x" s9 T+ Q# `70 Immunization in developing countries 1369
71 Community immunity 1395
' K  Y3 ?' z* X) X4 V$ W2 Y% q+ e72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
( }& |. c6 d( `% ~4 g) D& j9 c2 Q75 Regulation of vaccines in developing countries 1454
' W! |, q: j2 w# `. Y- V76 Vaccine safety 1464
% ?" x7 T& K& ]1 {# f77 Legal issues . 1481
3 D/ m6 A0 ^9 x78 Ethics 1508



9 H1 R" P# ^, N) a* K
2 J  r) w% s% T& x9 p$ [

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition
5 {  U# ^* _: s, }% e0 v
  d; J* n; j' D7 f* WApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
0 J( O4 ?5 d8 ~2 l# p# ?0 H
http://yun.baidu.com/share/link? ... 1&uk=3810996606
* ~& M: ?* r% Z
5 B& n& Z6 Z6 A4 qSECTION 1: General aspects of vaccination
! ]: D5 [8 P+ R5 [- q1 Y1 A short history of vaccination 1
8 o) L+ ~; S% M" k5 M2 Vaccine immunology 14
/ k: F' N3 a9 u2 T% a5 ?& k2 K3 The vaccine industry 33
4 Vaccine manufacturing 44
/ o5 b; w1 i0 R3 Z$ S1 u9 ?5 Evolution of adjuvants across the centuries 58
2 C  b& s5 ?6 \! P+ N% z9 f  O, l+ i6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
# n8 ~6 r$ r/ `7 v$ G# kSECTION 2: Licensed vaccines
- e" {( H) S% v3 A: q' o' a9 Adenovirus vaccines 113
10 Anthrax vaccines 127
$ j8 _( E. q5 ^. n/ n& l$ k$ b9 ^11 Cholera vaccines 141
  G8 R5 S% t; [8 M/ @/ T12 Diphtheria toxoid 153
6 X, x8 g7 n3 M/ }0 W13 Haemophilus influenzae vaccines 167
5 n; O7 c; [5 \- B$ E0 ~14 Hepatitis A vaccines 183
6 b( u8 l$ A2 J5 P! D* L1 X5 K15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
/ [0 e1 H  C! Z5 f1 L17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
4 D. s6 v; z7 G* P21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
6 O: s3 }# U! K) w2 K# k+ b26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
! Z! {: {, C6 q4 g% C# [. \28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
# _* p  z6 s; C) I, `31 Rubella vaccine 688
4 X2 b5 L1 I; m4 }32 Smallpox and vaccinia 718
, N" r, U6 M2 ]$ g& O. w, y5 S33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
, g2 K5 ~% L4 i1 z. i( I1 M35 Tuberculosis vaccines 789
. r$ p, a, W% a: a6 @36 Typhoid fever vaccines 812
0 o2 d) B$ [9 [4 }6 d7 x4 X37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
+ b( {, H) @/ g" ?) w# P40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
% p) a; `& h2 r" Y) d41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
* S. K3 y$ O* Y8 p! E  M1 W43 Cytomegalovirus vaccines 1032
+ k7 G% ]& |+ |9 U$ @# `8 X44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
( I; k4 j" t" O50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
4 d' M6 ?) u( B5 T52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
  O. k7 _, F' D+ |# O7 Q2 v5 f2 t56 Parasitic disease vaccines 1154
- k. a1 s" ^2 H& F: U57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
% I; I2 G/ |" V" O61 Alternative vaccine delivery methods 1200
7 w3 [) Q2 E4 v7 P& a62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
4 G- w- S- b8 Y63 Vaccination of immunocompromised hosts 1243
; ]% Z* F/ G: f0 @/ E" v, ^5 T64 Vaccination of human immunodeficiency virus-infected persons 1257
+ ]9 X  B  X1 N3 X9 a65 Vaccines for international travel 1270
; k* Q$ c$ ?& S' `" \- [) e66 Vaccines for health care personnel 1290
" G3 O$ W! y% ]* n$ t! k# t$ cSECTION 5: Public health and regulatory issues
. h/ u# ^/ f, E* n, v0 ~- t3 |' B67 Immunization in the United States 1310
& G5 B; B2 o8 r: j; q68 Immunization in Europe . 1334
/ y& s) Y. a- C* L) }69 Immunization in the Asia-Pacific region 1353
5 C! {# F% l8 H1 Q' T70 Immunization in developing countries 1369
71 Community immunity 1395
. k- z! J: l- v72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
0 F% x0 t2 X8 H$ e2 D74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
. U; \3 E1 e3 Q76 Vaccine safety 1464
7 L; p5 X/ K' v2 S77 Legal issues . 1481
4 s7 {. F1 z2 {; R/ D5 V) R78 Ethics 1508
5 k: Z6 {, y' a

' C- _' ~  K3 `, J( g) _

casarett

Vaccines, 6e, 2012
) J' u- L3 Y8 i; W) W: R/ @
( \  r8 ?9 |0 v# ^, uHardcover: 1570 pages
) y9 t, @# v$ _4 tPublisher: Saunders; 6 edition (October 30, 2012)
) f6 d4 L  \8 R. ?2 R  `Language: English
1 q; O( s. `5 xISBN-10: 1455700908
Size: 52.3mb (original pdf)

' K% \5 P) k- D) t( w: g9 I* }2013 BMA Medical Book Awards Highly Commended in Public Health!
2 o7 ?- x6 L+ t1 gApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
1 N% V5 E" b, v* n& }+ U
Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
9 `3 I, Z% N% r9 AGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
. u, {7 [9 c3 ]) `Analyze the cost-benefit and cost-effectiveness of different vaccine options.
& V( `; m/ f# n# n% j5 rClearly visualize concepts and objective data through an abundance of tables and figures.
& D3 M" D  V, GPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
" o+ R  [% o( _. q2 n4 ^Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
' ?3 U. I5 p  c5 D! P& ^6 \Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

Download link: http://pan.baidu.com/s/1i5NxwLR
3 y5 O8 t# R( G5 E4 SCode for downloading: dv96